Document is current
Any future updates will be listed below
-
Authors
Kida, Shuhei
Suga, Makiko
Yamaguchi, Yuta
Ikeda, Shunya
Kogue, Yosuke
Kawamoto, Ryuhei
Shibata, Kumi
Tsutsumi, Kazuhito
Murakami, Hiraku
Mizuta, Emiko
Mizutani, Yo
Hosen, Naoki
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (22cm0106381 and 25ama22134)
Japan Society for the Promotion of Science (JPJSBP120237202 and JP20H03710)
Takeda Science Foundation
- License Information
-
More Information
Article History
Received: 6 October 2025
Accepted: 16 February 2026
First Online: 2 March 2026
Declarations
:
: N.H. has applied for a Japanese patent entitled Antibodies against CLL-1 through the University of Osaka Office for University–Industry Collaboration. The other authors declare no competing financial interests.
: All mouse experiments were approved by the Administrative Panel on Laboratory Animal Care at University of Osaka (Protocol No. 03–045-023). Human sample collection and experimental procedures were approved by the Institutional Review Board of University of Osaka, and written informed consent was obtained from all participants.
